SmartCelle is Altus Formulation's proprietary polymeric micellar technology for parenteral, oral and topical delivery of insoluble molecules. SmartCelle enables delivery of Altus and its partner's cannabinoid and other insoluble drug candidates. Altus is pleased to announce that it has partnered with Evonik's Business Line, Health Care to scale, manufacture and provide clinical and commercial supplies of the SmartCelle polymers. SmartCelle technology is protected by a range of issued patents around the globe.
"We were very impressed with Evonik's polymer chemistry expertise and their deep understanding of biopolymer manufacturing; it was a simple choice to make," Damon Smith CEO Altus said.
"We look forward to working with Altus and to scaling their exciting new technology," Andreas Karau, Global Head of Biomaterials for Evonik, said.